Is a New Schizophrenia Drug Really a Gamer Changer? (quoting Kim Mueser and Daniel Fulford)
(10/7/2024, Futurity)
Expert Quote:
“The data so far do not suggest the drug is game-changing from an efficacy standpoint,[but] that there are significant reductions in overall symptoms, including both typical symptoms of psychosis, like hallucinations and delusions, and symptoms like mood or anxiety,” says Kim Mueser, a professor of occupational therapy.
“The initial results of clinical trials compare Cobenfy with a placebo and show significantly greater effects on psychotic symptoms, with some effects also found for more improvement in negative symptoms—reduced motivation and drive—and cognitive functioning: attention and concentration, memory, etc. FDA approval is for the treatment of psychotic symptoms, “ says Daniel Fulford an associate professor of occupational therapy.